News That Matters

Tag: life sciences

Engaging vulnerable populations: Making the right connections for better health
Health

Engaging vulnerable populations: Making the right connections for better health

A woman from a low-income neighborhood chooses not to receive care from her closest health center, which is located in a wealthy community, because of a demeaning interaction she previously had with the office staff there. A Spanish-speaking man whose prostate cancer has been in remission avoids making a follow-up appointment because he’s uncomfortable navigating discussions with staff in English. His daughter would go with him if he asked, but he doesn’t want to impose. Instead, he takes his chances and stays home. As these two examples demonstrate, barriers to healthcare access among those most vulnerable go beyond social determinants of health (SDoH) such as lack of reliable transportation or economic instability. Cultural, racial and socioeconomic barriers also play a role, from ...
Wilson Sonsini Adds Seth Flaum in New York to Expand Technology Transactions Department
Technology

Wilson Sonsini Adds Seth Flaum in New York to Expand Technology Transactions Department

Addition Reflects the Continued Growth of the New York Office and High Demand for Transactional Experience Among Life Sciences Clients Contact:Wayne KesslerBaretz+Brunelle732.239.9710 Mobilewkessler@baretzbrunelle.com PALO ALTO, CA (August 25, 2022) – Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Seth Flaum has joined the firm’s technology transactions department as a partner in the New York office, where he will focus on representing life sciences clients. He brings more than 25 years of broad transactional experience, representing companies in complex strategic transactions and various corpora...
Signify Health Considers Strategic Alternatives, Including a Sale
Health

Signify Health Considers Strategic Alternatives, Including a Sale

Signify Health is working with bankers to explore strategic alternatives including a sale, according to people familiar with the matter, roughly 18 months after the healthcare-services company’s initial public offering of stock.Signify Health, which had a market value of more than $4 billion on Tuesday afternoon, supplies technology that helps health plans and providers with in-home care. It could attract interest from private-equity firms as well as managed-care providers, the people said. Source link
Bausch Health Stock Halted After Patent Ruling. What Happens Next.
Health

Bausch Health Stock Halted After Patent Ruling. What Happens Next.

Text size Bausch Health stock was on pace for its lowest close since November 1995. Timothy Fadek/Bloomberg A federal court ruling has dealt a blow to Bausch Health by appearing to clear the way for generic competition for the company’s drug Xifaxan. Bausch Health stock (ticker: BHC) plummeted more than 50% Thursday ...